XVIVO Perfusion: The European study is a confirmation of the success in Australia and New Zeeland - Redeye

XVIVO presented the overall results from the European Heart study, based on 203 patients across 15 centers in 8 countries. The actual results are a robust improvement compared with the standard of care, and we look forward to a formal approval and launch in late 2024.

Länk till analysen i sin helhet: https://www.redeye.se/research/995282/xvivo-perfusion-the-european-study-is-a-confirmation-of-the-success-in-australia-and-new-zeeland?utm_source=finwire&utm_medium=RSS